MNKD — MANNKIND CORP

Ownership history in Bayesian Capital Management, LP  ·  6 quarters on record

This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in MANNKIND CORP (MNKD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.46% (2025 Q4)
Avg. % of fund
0.11%
First filed
2022 Q2
Last filed
2025 Q4
Quarters held
6
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 REDUCED 35,200 -21,609 -38.0% 0.46% $200K $5.67
2024 Q1 REDUCED 56,809 -1,300 -2.2% 0.02% $257K $4.53
2023 Q4 ADDED 58,109 +25,309 +77.2% 0.02% $212K $3.64
2023 Q3 REDUCED 32,800 -84,500 -72.0% 0.02% $135K $4.13
2022 Q3 ADDED 117,300 +54,200 +85.9% 0.07% $362K $3.09
2022 Q2 INITIATED 63,100 — — 0.04% $240K $3.81
% of Fund (quarterly)    MNKD price (monthly, adj. close)

Other funds also holding MNKD

As of 2025 Q4 — sorted by position size

Nitorum Capital, L.P. 3Y 7Y 6.68% TSP Capital Management Group, LLC 3Y 7Y 4.11% 180 WEALTH ADVISORS, LLC 3Y 7Y 1.91% APIS CAPITAL ADVISORS, LLC 3Y 7Y 1.19% 1492 Capital Management LLC 3Y 7Y 1.16% DELTEC ASSET MANAGEMENT LLC 3Y 7Y 0.92% SCOPIA CAPITAL MANAGEMENT LP 3Y 7Y 0.81% Frazier Life Sciences Management, L.P. 3Y 0.64% Eversept Partners, LP 3Y 7Y 0.53% Rubric Capital Management LP 3Y 7Y 0.51%
← Back to Bayesian Capital Management, LP Holdings